Collectively, these findings indicate that the anti-AML efficacy of N-8 is CTSD-dependent, effectively inhibiting proliferation and inducing apoptosis in leukemia cells with high CTSD expression. The gene discussed is CTSD; the disease is acute myeloid leukemia.